Lisa Peraza - 25 Jul 2023 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role: VP, Chief Accounting Officer
Signature: /s/ Lisa Peraza
Issuer symbol: HRTX
Transactions as of: 25 Jul 2023
Net transactions value: -$22,881
Form type: 4
Filing time: 17 Oct 2023, 19:57:53 UTC
Previous filing: 19 Jul 2023
Next filing: 16 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HRTX	Common Stock	Options Exercise		+42,631	+168%		67,941	25 Jul 2023	Direct	F1
transaction	HRTX	Common Stock	Tax liability	$22,262	-14,743	-22%	$1.51	53,198	25 Jul 2023	Direct	F2
transaction	HRTX	Common Stock	Options Exercise		+552	+1%		53,750	13 Oct 2023	Direct	F1
transaction	HRTX	Common Stock	Options Exercise		+1,932	+3.6%		55,682	13 Oct 2023	Direct	F1
transaction	HRTX	Common Stock	Tax liability	$619	-860	-1.5%	$0.7200	54,822	13 Oct 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HRTX	Performance Stock Units	Options Exercise	$0	-42,631	-100%	$0.000000^*	0	25 Jul 2023	Common Stock	42,631		Direct	F1, F3
transaction	HRTX	Restricted Stock Units	Options Exercise	$0	-552	-20%	$0.000000	2,208	13 Oct 2023	Common Stock	552		Direct	F1, F4
transaction	HRTX	Restricted Stock Units	Options Exercise	$0	-1,932	-20%	$0.000000	7,964	13 Oct 2023	Common Stock	1,932		Direct	F1, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.
F3	On July 25, 2022, the Compensation Committee of the Issuer (the "Committee") granted the Reporting Person Performance Stock Units ("PSUs"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs were further subject to a time-based vesting schedule. The PSUs vested in full on the first anniversary of the grant date (July 25, 2023).
F4	The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).
F5	The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).